Colorectal cancer chemotherapy: Irinotecan

被引：0
|
作者：
Rougier, P [1 ]
Mitry, E [1 ]
机构：
[1] Hop Ambroise Pare, Dept GastroEnterol & Digest Oncol, F-92100 Boulogne, France
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 143
页数：6
相关论文
共 50 条
  • [21] Irinotecan in colorectal cancer in elderly patients with advanced colorectal cancer
    Sastre, J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 : S22 - S22
  • [22] Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer
    Lucía Cortejoso
    María I. García
    Pilar García-Alfonso
    Eva González-Haba
    Fernando Escolar
    María Sanjurjo
    Luis A. López-Fernández
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1463 - 1472
  • [23] Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer
    Goldberg, RM
    Gill, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (Suppl 1) : S57 - S64
  • [24] Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Aparicio, T
    Mitry, E
    Ezenfis, J
    Dominguez, S
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 2051 - 2052
  • [25] Irinotecan (CPT-11)-based chemotherapy as induction treatment for advanced colorectal cancer
    Quintela-Fandino, M
    Gravalos, C
    Gonzalez, E
    Garcia-Velasco, A
    Cortés-Funes, H
    ANTI-CANCER DRUGS, 2005, 16 (01) : 31 - 38
  • [26] Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer
    Cortejoso, Lucia
    Garcia, Maria I.
    Garcia-Alfonso, Pilar
    Gonzalez-Haba, Eva
    Escolar, Fernando
    Sanjurjo, Maria
    Lopez-Fernandez, Luis A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1463 - 1472
  • [27] Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    T Aparicio
    E Mitry
    J Ezenfis
    S Dominguez
    British Journal of Cancer, 2004, 90 : 2051 - 2052
  • [28] Current place of high-dose irinotecan chemotherapy in patients with metastatic colorectal cancer
    Mohamed Hebbar
    Marc Ychou
    Michel Ducreux
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 749 - 752
  • [29] Irinotecan as a second line chemotherapy in advanced and metastatic colorectal cancer. Is that appropriate regimen?
    Chilikidi, KY
    Lazarev, AF
    Doty, IN
    CLINICAL CANCER RESEARCH, 1999, 5 : 3775S - 3775S
  • [30] Phase II trial of irinotecan and raltitrexed in chemotherapy-naive advanced colorectal cancer
    Chiara, S
    Nobile, MT
    Tomasello, L
    Acquati, M
    Taveggia, P
    Murolo, C
    Percivale, P
    Rosso, R
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1391 - 1396
12345